The incidence and epidemiology of plasma cell neoplasms.

The incidence and epidemiology of plasma cell neoplasms.

Item
http://www.wikidata.org/entity/Q40921936
Clinicopathological characteristics of extremely young Korean multiple myeloma patients: therapeutic implications.Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.The role of serum protein electrophoresis in the detection of multiple myeloma: an experience of a corporate hospital.Syndecan-1: a dynamic regulator of the myeloma microenvironment.More frequent IgD and reduced CD200 expression in Chinese patients younger than 50 years old with multiple myeloma: a multicenter analysis.Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins.Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth.Bisphosphonates and statins inhibit expression and secretion of MIP-1α via suppression of Ras/MEK/ERK/AML-1A and Ras/PI3K/Akt/AML-1A pathways.Myeloma (multiple).
P2860

The incidence and epidemiology of plasma cell neoplasms.

Item
http://www.wikidata.org/entity/Q40921936
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The incidence and epidemiology of plasma cell neoplasms.
@en
type
label
The incidence and epidemiology of plasma cell neoplasms.
@en
prefLabel
The incidence and epidemiology of plasma cell neoplasms.
@en
P1433
P1476
P2093
P304
P31
P478
P577
P698
P1433
P1476
The incidence and epidemiology of plasma cell neoplasms.
@en
P2093
P304
P31
P478
P577
P698